BBLG
Bone Biologics
BBLG
BBLG
3 hedge funds and large institutions have $43K invested in Bone Biologics in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$8K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $35K | 33,461 | – | – |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $8K | 7,877 | +1,712 | +28% |
|
|
3
UBS Group
Zurich,
Switzerland
| – | – | -7,673 | Closed |
|
|
CFGS
4
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
5
Wells Fargo
San Francisco,
California
| $0 | 21 | +21 | New |
|